Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy

Immunotherapy for cancer is a rapidly developing treatment that modifies the immune system and enhances the antitumor immune response. B7-H3 (CD276), a member of the B7 family that plays an immunoregulatory role in the T cell response, has been highlighted as a novel potential target for cancer immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Binghao, Li, Huanzhang, Xia, Yu, Wang, Yaning, Wang, Yuekun, Shi, Yixin, Xing, Hao, Qu, Tian, Wang, Yu, Ma, Wenbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597993/
https://www.ncbi.nlm.nih.gov/pubmed/36284349
http://dx.doi.org/10.1186/s13045-022-01364-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597993/
https://www.ncbi.nlm.nih.gov/pubmed/36284349
http://dx.doi.org/10.1186/s13045-022-01364-7

Ejemplares similares